Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.

Abstract

Novel Boc-CCK-4 derivatives were communicated recently as having high potency and selectivity for the CCK-A receptor (Shiosaki et al. J. Med. Chem. 1990, 33, 2950-2952). While Boc-CCK-4 binds selectively to the CCK-B receptor, replacement of the methionine with an N epsilon-substituted lysine dramatically reversed receptor selectivity, leading to the… (More)

Topics

  • Presentations referencing similar topics